Trustmark National Bank Trust Department Pfizer Inc Transaction History

Trustmark National Bank Trust Department

$1.24 Billion
Q2 2024

A detailed history of Trustmark National Bank Trust Department transactions in Pfizer Inc stock. As of the latest transaction made, Trustmark National Bank Trust Department holds 33,193 shares of PFE stock, worth $949,651. This represents 0.07% of its overall portfolio holdings.

Number of Shares

33,193

Previous 35,985 7.76%

Holding current value

$949,651

Previous $998,000 7.01%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $70,525 - $82,643	-2,792 Reduced 7.76%	33,193 $928,000
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $2.17 Million - $2.5 Million	-84,001 Reduced 70.01%	35,985 $998,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.13 Million - $1.47 Million	43,265 Added 56.39%	119,986 $3.45 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $3,626 - $4,238	-113 Reduced 0.15%	76,721 $2.54 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $212,024 - $245,307	-5,870 Reduced 7.1%	76,834 $2.82 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $135,462 - $176,351	-3,439 Reduced 3.99%	82,704 $3.37 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $177,395 - $231,570	-4,249 Reduced 4.7%	86,143 $4.42 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $11,158 - $13,622	-255 Reduced 0.28%	90,392 $3.96 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $50,857 - $60,300	1,093 Added 1.22%	90,647 $4.75 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $62,906 - $77,948	-1,375 Reduced 1.51%	89,554 $4.64 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $93,052 - $137,935	2,252 Added 2.54%	90,929 $5.37 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $230,907 - $296,620	-5,883 Reduced 6.22%	88,677 $3.81 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $122,093 - $138,312	-3,400 Reduced 3.47%	94,560 $3.7 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $389,321 - $439,076	-11,625 Reduced 10.61%	97,960 $3.55 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $641,653 - $815,917	-19,171 Reduced 14.89%	109,585 $4.03 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $379,825 - $445,621	11,963 Added 10.24%	128,756 $4.73 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $184,334 - $223,624	6,120 Added 5.53%	116,793 $3.82 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $120,310 - $171,897	-4,451 Reduced 3.87%	110,673 $3.61 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $84,176 - $95,529	-2,557 Reduced 2.17%	115,124 $4.51 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $162,125 - $210,228	-4,990 Reduced 4.07%	117,681 $4.23 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $178,021 - $199,877	-4,814 Reduced 3.78%	122,671 $5.31 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $45,375 - $49,852	-1,210 Reduced 0.94%	127,485 $5.41 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $144,685 - $164,957	3,761 Added 3.01%	128,695 $5.62 Million
Q3 2018 Feb 22, 2019	SELL	$34.47 - $41.81 $559,172 - $678,241	-16,222 Reduced 11.49%	124,934 $5.51 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $573,132 - $695,174	16,627 Added 13.35%	141,156 $6.22 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $7,321 - $7,805	-222 Reduced 0.18%	124,529 $4.52 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $201,064 - $233,263	-6,301 Reduced 4.81%	124,751 $4.43 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $97,717 - $103,682	2,938 Added 2.29%	131,052 $4.75 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $3.97 Million - $4.38 Million	128,114	128,114 $4.57 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Trustmark National Bank Trust Department with notifications on news.

Account

Trustmark National Bank Trust Department Pfizer Inc Transaction History